Numerous emerging therapies for focused treatments on psoriasis and psoriatic arthritis (PsA) are authorized. Tumor necrosis factor (TNF) inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, selective co-stimulation modulators, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors are among the biologics that are added to the treatment regime for psoriasis and PsA in recent years. Join an exclusive session with "Emerging Treatments for Psoriasis” with eminent dermatologist, Dr. Col. Biju Vasudevan , on 1 st August 2024 , 11:00 AM IST onwards .
Moderator : Dr. Rashmi Mahajan Stay Tuned! Suggested readings Lesions in a Psoriasis Patient (Case Challenge) Secukinumab for Plaque Psoriasis: Evidence Based on the Real-world Clinical Scenario ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we…
